Endo Announces New Peyronie’s Disease Data Presented at the American Urological Association Annual Meeting

MALVERN, Pa., May 7, 2024 /PRNewswire/ — Endo, Inc. announced today that three new presentations related to Peyronie’s disease and XIAFLEX® (collagenase clostridium histolyticum) were shared during the American Urological Association (AUA) annual meeting, which took place May 3-6, 2024….

Privacy Overview

This website uses cookies so that we can provide you with the best user experience possible. Cookie information is stored in your browser and performs functions such as recognising you when you return to our website and helping our team to understand which sections of the website you find most interesting and useful.